Xiaoke Guo Selected Research

Kv1.5 Potassium Channel

12/2022	Design, synthesis, and biological evaluation of arylmethylpiperidines as Kv1.5 potassium channel inhibitors.
6/2014	Discovery of 1-aryloxyethyl piperazine derivatives as Kv1.5 potassium channel inhibitors (part I).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoke Guo Research Topics

Disease

5	Neoplasms (Cancer) 01/2021 - 04/2010
3	Cardiac Arrhythmias (Arrythmia) 12/2022 - 01/2014
2	Atrial Fibrillation 12/2022 - 06/2014
2	Hypoxia (Hypoxemia) 01/2018 - 01/2017
1	Leukemia 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Speech Disorders (Cluttering) 01/2016
1	Reperfusion Injury 12/2014

Drug/Important Bio-Agent (IBA)

2	Kv1.5 Potassium ChannelIBA 12/2022 - 06/2014
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2015
1	MethyltransferasesIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2017
1	UbiquitinIBA 01/2015
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2015
1	Ion Channels (Ion Channel)IBA 12/2014
1	Potassium Channels (Potassium Channel)IBA 01/2014
1	PiperazineIBA 01/2014
1	gambogic acidIBA 04/2010
1	Methanol (Carbinol)IBA 04/2010

Therapy/Procedure

1	Oral Administration 01/2021
1	Aftercare (After-Treatment) 01/2016
1	Therapeutics 01/2015